(3S,5S)-3-异丙基-2-氧代-5-[(2S,4S)-四氢-4-异丙基-5-氧代-2-呋喃基]-1-吡咯烷羧酸叔丁酯合成路线 (共 5 条)
反应条件
1: (3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxo-tetrahydro-furan-2-yl)pyrrolidin-2-one With 4-(N,N-dimethlyamino)pyridine; triethylamine in isopropanol acetate
T=40 - 45°C;
2: di-tert-butyl dicarbonate in isopropanol acetate
T=40 - 45°C;
参考文献
NOVARTIS AG; NOVARTIS PHARMA GmbH
Patent: WO2007/45420 A2, 2007 ;
Location in patent: Page/Page column 63-64 ;
反应条件
4-methylmorpholine N-oxide; tetrapropylammonium perruthennate in dichloromethane; acetonitrile
T=20°C; Molecular sieveHeating / reflux; Product distribution / selectivity;
参考文献
NOVARTIS AG
Patent: WO2008/119804 A1, 2008 ;
Location in patent: Page/Page column 61-62 ;
WO 2008/119804 A1
反应条件
1: 4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene With n-butyllithium in tetrahydrofuran; hexane
T=-70°C; 2 h;
2: (3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester in tetrahydrofuran; hexane
T=-70 - -50°C;
3: With water; citric acid in tetrahydrofuran; hexane
T=0 - 5°C; 0.333333 h;
参考文献
NOVARTIS AG; NOVARTIS PHARMA GmbH
Patent: WO2007/45420 A2, 2007 ;
Location in patent: Page/Page column 64-66 ;
反应条件
in tetrahydrofuran
T=-70°C; 0.583333 h;
参考文献
NOVARTIS AG; NOVARTIS PHARMA GmbH
Patent: WO2007/45420 A2, 2007 ;
Location in patent: Page/Page column 68-69 ;
反应条件
in tetrahydrofuran
T=-10°C; 16 - 17 h;
参考文献
NOVARTIS AG; NOVARTIS PHARMA GmbH
Patent: WO2007/45420 A2, 2007 ;
Location in patent: Page/Page column 67-68 ;